Liver metastases after curative resection in patients with distal bile duct cancer

British Journal of Surgery

Volumn 86, Issue 3, 1999, Pages 327-331

  Takao, S ^a   Shinchi, H ^a   Uchikura, K ^a   Kubo, M ^a   Aikou, T ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BILE DUCT CANCER; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL RATE; TUMOR CLASSIFICATION; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0033046285     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01018.x     Document Type: Article

References (26)

1. Wade TP, Prasad CN, Virgo KS, Johnson FE. Experience with distal bile duct cancers in US Veterans Affairs hospitals: 1987-1991. J. Surg Oncol 1997; 64: 242-5.
2. Fong Y, Blumgart LH, Lin E, Fortner JG, Brennan MF. Outcome of treatment for distal bile duct cancer. Br J Surg 1996; 83: 1712-15.
3. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993; 217:430-5.
4. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165: 68-73.
5. Pellegrini CA, Heck CF, Raper S, Way LW. An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy. Arch Surg 1989; 124: 778-81.
6. Trede M, Schwall G, Saeger HD. Survival after pancreaticoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990; 211: 447-58.
7. Carey LC. Pancreaticoduodenectomy. Am J Surg 1992; 164: 153-62.
8. Allema JH, Reinders ME, van Gulik TM, Koelemay MJ, Van Leeuwen DJ, de Wit LT et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 1995; 75: 2069-76.
9. Ouchi K, Matsuno S, Sato T. Long-term survival in carcinoma ot the biliary tract. Analysis of prognostic factors in 146 resections. Arch Surg 1989; 124: 248-52.
10. Kayahara M, Nagakawa T, Tsukioka Y, Ohta T, Ueno K, Miyazaki I. Neural invasion and nodal involvement in distal bile duct cancer. Hepatogastroenterology 1994; 41: 190-4.
11. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA et al. Six hundred fifty consecutive pancreaticoduodenectomics in the 1990s: pathology, complications, and outcomes. Ann Surg 1997; 226: 248-57.
12. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors. 5th ed. New York: Wiley-Liss, 1997.
13. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224: 463-73.
14. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J. Am Stat Assoc 1958; 53: 457-81.
15. Prentice R. Use of the logistic model in retrospective studies. Biometrics 1976; 32: 599-606.
16. Cox DR. Regression models and life tables. J R Stat Soc Ser B 1972; 34: 187-220.
17. Tompkins RK, Thomas D, Wile A, Longmire WP Jr. Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg 1981; 194: 447-57.
18. Chao TC, Greager JA. Carcinoma of the extrahepatic bile ducts. J Surg Oncol 1991; 46: 145-50.
19. Rossi RL, Gagner M, Heiss FW, Shea JA. Resective operations for biliary carcinoma. Jpn J Surg 1990; 20: 613-19.
20. Chan C, de Herrera MF, la Garza L, Quintanilla Martinez L, Vargas Vorackova F, Richaud Patin Y et al. Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg 1995; 222: 632-7.
21. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996; 77: 858-63.
22. Tomisaki S, Ohno S, Ichiyoshi Y, Kuwano H, Maehara Y, Sugimachi K. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 1996; 77(8 Suppl): 1722-8.
23. Takebayashi Y, Natsugoe S, Baba M, Fukumoto T, Takao S, Akiba S et al. Angiogenesis in esophageal squamous cell carcinoma. Oncol Rep 1998; 5: 401-4.
24. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995; 95: 1789-97.
25. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996; 88: 1110-17.
26. Takao S, Takebayashi Y, Che X, Shinchi H, Natsugoe S, Miyadera K et al. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Clin Cancer Res 1998; 4: 1619-24.